Menu

Aptevo Therapeutics Inc. APVO

Full chart Compare
Set alert

Price alert · APVO

All alert types
1.24 USD -0.03 (-2.36%)

At closeNov 6, 2026, 7:58 PM EST

1.25 +0.01 +0.81%

After hours · Nov 6, 7:58 PM ET

1.20 Day range 1.32
1.24 52-week range 28.08
YTD
-86.85%
1 year
-95.31%

Revenue & Expenses

Other Income → Gross Profit & Other Income: $36.67MGross Profit & Other Income → Net Income: $8.03MGross Profit & Other Income → Selling, General & Admin: $13.87MGross Profit & Other Income → Research & Development: $17.88MGross Profit → Gross Profit & Other Income: $3.11MRevenue → Gross Profit: $3.11MOther Income$36.67MGross Profit$3.11MGross Profit & Other Income$39.78MNet Income$8.03MSelling, General & Admin$13.87MResearch & Development$17.88MRevenue$3.11M

Latest period ending Dec 31, 2025 · select a line to chart its full history

APVO annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-26.31M-24.60M-28.88M-28.64M-21.40M
-25.97M-24.13M-17.41M8.03M-28.46M
-87.27-31,460.23-834,059.00920,146.00-3,557,506.00
APVO annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
21.62M8.71M16.90M22.64M46.30M
27.19M15.59M24.84M34.22M56.60M
9.81M10.84M12.62M16.24M55.38M
4.63M5.40M5.40M9.54M16.71M
17.38M4.75M12.22M17.97M1.22M
APVO annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-25.59M-23.79M-11.73M-21.02M-21.68M
38.50M15.60M6.00M-2.62M26.16M
12.90M-8.19M-5.73M-23.67M3.77M